^
BIOMARKER:

EGFR mutation + KRAS mutation

i
Other names: KRAS, KRAS1, KRAS2, Kirsten rat sarcoma viral oncogene homolog, EGFR, ERBB, ERBB1, Epidermal growth factor receptor
Entrez ID:
EGFR mutation + KRAS mutation
Lung Non-Squamous Non-Small Cell Cancer
Tyrosine kinase inhibitor
Sensitive: C3 – Early Trials
EGFR mutation + KRAS mutation
NSCLC
Tyrosine kinase inhibitor
Resistant: C3 – Early Trials
EGFR mutation + KRAS mutation
LUAD
Tyrosine kinase inhibitor
Resistant: C3 – Early Trials
EGFR mutation + KRAS mutation
CRC
cetuximab
Resistant: D – Preclinical